What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-03-31 compared with 2022-03-31 · 34 added, 30 removed, 9 unchanged (88% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

MARKET FOR REGISTRANT’S COMMON

EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our equity securities trade on the Nasdaq.

Each of our units consists

of one Class A ordinary share and one warrant and, commencing on September 3, 2021, trades on the Nasdaq under the symbol “OXUSU.”

The Class A ordinary shares and warrants underlying our units began trading separately on the Nasdaq under the symbols “OXUS”

and “OXUSW,” respectively, on October 6, 2021.

of our units consists of one Class A ordinary share and one warrant and, commencing on September 3, 2021, trades on the Nasdaq under the

symbol “OXUSU.” The Class A ordinary shares and warrants underlying our units began trading separately on the Nasdaq under

the symbols “OXUS” and “OXUSW,” respectively, on October 6, 2021.

Holders of Record

On March 4, 2022, there were 1 holder of record of our units and 3

holders of record of our Class A ordinary shares and 6 holders of record of our warrants.

Such numbers do not include beneficial owners

holding our securities through nominee names.

We have not paid any cash dividends on our ordinary shares to date

and do not intend to pay cash dividends prior to the completion of our initial business combination.

The payment of cash dividends in

the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to

completion of our initial business combination.

The payment of any cash dividends subsequent to our initial business combination will

be within the discretion of our board of directors at such time.

In addition, our board of directors is not currently contemplating and

does not anticipate declaring any share dividends in the foreseeable future.

On March 24, 2023, there were one holder of record

of our units and three holders of record of our Class A ordinary shares and five holders of record of our warrants.

Such numbers do not

include beneficial owners holding our securities through nominee names.

We have not paid any cash dividends on our ordinary

shares to date and do not intend to pay cash dividends prior to the completion of our initial Business Combination.

The payment of cash

dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition

subsequent to completion of our initial Business Combination.

The payment of any cash dividends subsequent to our initial Business Combination

will be within the discretion of our board of directors at such time.

In addition, our board of directors is not currently contemplating

and does not anticipate declaring any share dividends in the foreseeable future.

Further, if we incur any indebtedness in connection with

1 unchanged sentence

Use of Proceeds from our Initial Public Offering

On September 8, 2021, the Company consummated the initial public offering

of 15,000,000 units at $10.00 per unit and the sale of 8,400,000 private warrants at a price of $1.00 per

private warrant in a private placement to the Company’s sponsor and its underwriters that closed simultaneously with the closing

of the initial public offering.

On September 8, 2021, the Company consummated

the Initial Public Offering of 15,000,000 units at $10.00 per unit and the sale of 8,400,000 private warrants

at a price of $1.00 per private warrant in a private placement to the Company’s sponsor and its underwriters that closed

simultaneously with the closing of the Initial Public Offering.

On September 13, 2021, the underwriters exercised their over-allotment

2 unchanged sentences

$23.40 million.

A total of $175,950,000 of the net proceeds from the initial public

offering (including the additional units) and the sale of private placement warrants and additional private placement warrants was deposited

in a trust account with Continental Stock Transfer & Company as trustee (“Trust Account”), established for the benefit

of the Company’s public stockholders.

Transaction costs amounted to $3.70 million

consisting of $3.00 million in cash of underwriting fees and $0.70 million of other offering costs.

For a description of the use of the proceeds generated in our initial

public offering, see Part II, Item 7 of this Annual Report.

A total of $175,950,000 of the net proceeds from the

Initial Public Offering (including the additional units) and the sale of private placement warrants and additional private placement warrants

was deposited in a trust account with Continental Stock Transfer & Company as trustee, established for the benefit of the Company’s

public shareholders.

Transaction costs amounted to $3.70 million consisting of $3.00 million in cash of underwriting fees

and $0.70 million of other offering costs.

In connection with the shareholder vote to approve

the Extension Amendment in the Extraordinary General Meeting on March 2, 2023, the holders of 15,300,532 Class A ordinary shares

property exercised their right to redeem their shares for cash at a redemption price of approximately $10.41 per share, for an aggregate

redemption amount of approximately $159.34 million, leaving approximately $20.3 million in the trust account.

For a description of the use of the proceeds generated

in our Initial Public Offering, see Part II, Item 7 of this Annual Report.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity